As of July 2025 Summit Therapeutics has a market cap of ยฃ15.26 Billion. This makes Summit Therapeutics the world's 1048th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | ยฃ15.26 B | 42.63% |
2024 | ยฃ10.70 B | 645.31% |
2023 | ยฃ1.43 B | 103.01% |
2022 | ยฃ0.70 B | 263.19% |
2021 | ยฃ0.19 B | -31.35% |
2020 | ยฃ0.28 B | 246.04% |
2019 | ยฃ81.96 M | 449.9% |
2018 | ยฃ14.9 M | -87.82% |
2017 | ยฃ0.12 B | 43.44% |
2016 | ยฃ85.3 M | -10.32% |
2015 | ยฃ95.12 M |
On Jul 28th, 2025 the market cap of Summit Therapeutics was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() Sarepta Therapeutics
SRPT | ยฃ1.01 B | -93.32% | ๐บ๐ธ USA |
![]() Arena Pharmaceuticals
ARNA | ยฃ4.61 B | -69.76% | ๐บ๐ธ USA |
![]() Merrimack Pharmaceuticals MACK | ยฃ0.16 B | -98.90% | ๐บ๐ธ USA |
![]() Coherus BioSciences
CHRS | ยฃ92.87 M | -99.39% | ๐บ๐ธ USA |